Table 2. Resistance patterns in a Mumbai cohort of HIV/MDR-TB co-infected patients.
Drug resistance profile | No previous TB treatment or first line treatment only | Previously exposed to second line drugs |
Suspected MDR-TB | 6 | 7 |
MDR, but no second line resistance | ||
HR | 1 | 1 |
HR+other first-line | 8 | 7 |
MDR with second line resistance (but not XDR) | ||
HR+Ofx | 7 | 11 |
HR+second-line injectable | 0 | 0 |
HR+Group 4 drugs | 6+ | 2 |
XDR | 2 | 0 |
including one strain with isoniazid susceptibility.
R: Rifampicin, H: Isoniazid, Ofx: ofloxacin.